Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with ulcerative colitis (UC), alterations of the intestinal microbiota, termed dysbiosis, have been postulated to contribute to intestinal inflammation. Fecal microbiota transplantation (FMT) has been used as effective therapy for recurrent Clostridium difficile colitis also caused by dysbiosis. The aims of the present study were to investigate if patients with UC benefit from FMT and if dysbiosis can be reversed. METHODS: Six patients with chronic active UC nonresponsive to standard medical therapy were treated with FMT by colonoscopic administration. Changes in the colonic microbiota were assessed by 16S rDNA-based microbial community profiling using high-throughput pyrosequencing from mucosal and stool samples. RESULTS: All patients experienced short-term clinical improvement within the first 2 weeks after FMT. However, none of the patients achieved clinical remission. Microbiota profiling showed differences in the modification of the intestinal microbiota between individual patients after FMT. In 3 patients, the colonic microbiota changed toward the donor microbiota; however, this did not correlate with clinical response. On phylum level, there was a significant reduction of Proteobacteria and an increase in Bacteroidetes after FMT. CONCLUSIONS: FMT by a single colonoscopic donor stool application is not effective in inducing remission in chronic active therapy-refractory UC. Changes in the composition of the intestinal microbiota were significant and resulted in a partial improvement of UC-associated dysbiosis. The results suggest that dysbiosis in UC is at least in part a secondary phenomenon induced by inflammation and diarrhea rather than being causative for inflammation in this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These reports were followed by a number of small studies of FMT in children and adults with UC, CD, and pouchitis with mixed results.64–72”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [69]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“, 16S rDNA) in combination with highthroughput sequencing techniques that enabled culture-independent surveys of human gut microbes.(32) Using these techniques, remarkable changes in the human gut microbiota in patients with IBD have been observed.”
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762 · cited 1×
“5.(25) Contaminant (human) sequences and singletons were manually removed.”
BackgroundFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“Using these techniques, remarkable changes in the human gut microbiota in patients with IBD have been observed.(6,30,33,34) These changes, also termed dysbiosis, are thought to be involved in the pathogenesis of IBD.”
BackgroundMethodDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 3×
“Changes of the intestinal microbiota after FMT have so far been studied only in recurrent CDI.(13,43) Successful FMT in CDI was associated with an increase in bacterial diversity and richness,(13,43) an increase of Bacteroidetes, Firmicutes, and butyrate-producing bacteria such as Lachnospiraceae, and a decrease in Pr…”
BackgroundCoated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026 · cited 1×
“During control visits, the clinical condition and endoscopic activity of UC were judged using the Mayo score.(20) A reduction of the total Mayo score by $3 points was considered as a clinical response, whereas a drop of the Mayo score to #2 points was considered as remission.”
MethodFord Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Research works printed but not linked: 1
- Lee, 2010, 330, 1768
Cited by
Items 201–234 of 234
Fäkale Mikrobiotatransplantation (FMT): Gesicherte Therapieindikationen und Zukunftsperspektiven
Lübbert, C. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0125-2 · Cited by 1
Faecal microbiota transplantation associated adverse events
Patryn, R. K., Kaźmierczak-Wojtaś, N., Bułaś, L., Boretska, O., Szkultecka-Dębek, M., Drozd, M., & Blicharski, T. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0028 · Cited by 2
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.
Moossavi, S., Bishehsari, F., Ansari, R., Vahedi, H., Nasseri‐Moghaddam, S., Merat, S., Sobhani, I., Keshavarzian, A., & Malekzadeh, R. (2015) · PubMed Central · Cited by 2
Fecal Microbiota Transplants: Current Knowledge and Future Directions
Chis, R., Sheth, P. M., & Petrof, E. O. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_11 · Cited by 2
SSAT State-of-the-Art Conference: Advancements in the Microbiome
Miller, M. O., Kashyap, P., Becker, S., Thomas, R. M., Hodin, R. A., Miller, G., Barry-Hundeyin, M., Pushalkar, S., Cohen, D. J., Saxena, D. B., et al. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-020-04551-4 · Cited by 2
Трансплантация фекальной микробиоты в лечении воспалительных заболеваний кишечника
Privalov, M. A., & Sizenko, A. K. (2014) · Likarska sprava · doi:10.31640/ls-2014-11-03 · Cited by 2
Fäkale Mikrobiotatransplantation („Stuhltransplantation“)
Kump, P. K., & Högenauer, C. (2014) · Die Gastroenterologie · doi:10.1007/s11377-014-0874-7 · Cited by 2
Self-citationFecal Microbial Transplant: For Whom, How, and When
Kahn, S. A., & Kaplan, J. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_35 · Cited by 1
Clinical Utility and Alterations in Bacterial Flora in Fecal Microbiome Transplantation
Dave, A. A., & Robson, R. L. (2015) · International Journal of Medical Students · doi:10.5195/ijms.2015.135 · Cited by 1
“At 90 days, none of the UC patients had remission of their disease, but at follow up one year post-FMT, three of the six treated patients had remission.(4)”
BackgroundMethodInfluentialTherapie bei chronisch entzündlichen Darmerkrankungen: Immunsuppressiva, Anti-TNFs und Neues
Ro, K., & Tilg, H. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
II. Fecal Microbiota Transplantation and Its Clinical Application
Ohkusa, T., & Koido, S. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.42
Bradyrhizobium enterica in Cord Colitis Syndrome
Specks, U., Iklé, D. N., & Stone, J. H. (2013)
Chan, C. (2016) · Scholarship - Claremont (Claremont Colleges)
1) Microbiota and Gastrointestinal Disease
Kanai∥, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.111a
Transplantatie van fecale microbiota : oude wijn in nieuwe zakken?
Holvoet, T., de Wiele, T. V., Boelens, J., Raes, J., Hindryckx, P., Vos, M. D., & Looze, D. A. D. (2014) · Ghent University Academic Bibliography (Ghent University)
Darmmikrobiom des Menschen: Status quo und Perspektiven
Clavel, T., & Hörmannsperger, G. (2017) · Pädiatrie up2date · doi:10.1055/s-0043-115278
“[81] Kump PK, Grochenig HP, Lackner S et al.”
BackgroundStudies of the aetiopathogenesis of pouchitis
Landy, J. (2014) · doi:10.25560/25735
Tiburcio, Á., Ruiz, H., & Reyes-López, P. A. (2019) · Open Journal of Bacteriology · doi:10.17352/ojb.000010 · Cited by 1
Microbes in the Pathogenesis of Inflammatory Bowel Disease: A Review
Jatwani, S., Malhotra, B. K., Crout, T. M., & Majithia, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-23311-2_37
Microbiome and Microbiota in Rheumatic Disease
Attur, M., & Scher, J. U. (2019) · Springer eBooks · doi:10.1007/978-3-030-23311-2_2
1) Microbiota and Gastrointestinal Disease
Kanai∥, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.1695
Lei, D., Xu, H., Peng, R., Yang, M., Li, X., Zuo, W., Gou, J., Yu, S., Huang, M., & Liu, H. (2021) · PubMed Central
Ramos, R. J. J. F., Zhu, C., Joseph, D. F., Thaker, S., LaComb, J. F., Markarian, K., Littmann, E. R., Lee, H. J., Petrov, J. C., Monzur, F., et al. (2022) · medRxiv · doi:10.1101/2022.02.11.22268733
Chen, H., Yi, B., Xu, X., Liu, Q., Dai, L., & Ma, Z. (2020) · doi:10.21203/rs.3.rs-41491/v1
Chen, H., Yi, B., Xu, X., Liu, Q., Dai, L., & Ma, Z. (2020) · Research Square · doi:10.21203/rs.3.rs-46116/v1
Fecal Microbiota Transplantation: Applications and Challenges in India
Banik, S., & Ramadass, B. (2023) · Gastroenterology Hepatology and Endoscopy Practice · doi:10.4103/ghep.ghep_37_22
Duquesnoy, M., Peyrin‐Biroulet, L., Viennois, É., & Chassaing, B. (2025) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2025.01.001 · Cited by 1
Novel Biologics for the Treatment of Ulcerative Colitis
Rashid, F., & Lichtenstein, G. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1677-1_17
Li, W., Sun, Y., Dai, L., Chen, H., Yi, B., Niu, J., Wang, L., Zhang, F., Luo, J., Wang, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14539007
Écale, F. (2021) · theses.fr (ABES) · doi:10.70675/f456a090zae0fz489czb8e9z6739bf2d74ae · Cited by 1
Strain-level ecological filtering governs microbial colonization of the human gut
Baertschi, I., Jordi, S. B. U., Gardaz, L. J., Bigi, F. V., Sokollik, C., Juillerat, P., & Yılmaz, B. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117775 · Cited by 1
Wang, J., Zhang, X., Song, X., He, Y., Lang, W., & Zhang, X. (2026) · Veterinary Sciences · doi:10.3390/vetsci13090976
Bacteriotherapy reintroduces “old friends” in IBD
Nanki, K., Naganuma, M., Mizuno, S., Matsuoka, K., & Kanai∥, T. (2015) · Inflammation and Regeneration · doi:10.2492/inflammregen.35.122
Metadata
- Authors
- Kump, P. K., Gröchenig, H.-P., Lackner, S., Trajanoski, S., Reicht, G., Hoffmann, K. M., Deutschmann, A., Wenzl, H. H., Petritsch, W., Krejs, G. J., Gorkiewicz, G., & Högenauer, C.
- Affiliations
- Medical University of Graz (AT)
- Hospital of the Brothers of St. John of God (AT)
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09
- Volume
- 19
- Issue
- 10
- Pages
- 2155-2165
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W1983728610
- Cited by
- 235
- References
- 49
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 11 · 2020: 17 · 2019: 16 · 2018: 19 · 2017: 28 · 2016: 32 · 2015: 41 · 2014: 35 · 2013: 6
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, ulcerative colitis
- MeSH terms
- Adolescent, Adult, Biological Therapy, Chronic Disease, Clostridium Infections, Colitis, Ulcerative, Feces, Female, Follow-Up Studies, Humans, Intestines, Male, Middle Aged, Phylogeny, Prognosis, Remission Induction, RNA, Ribosomal, 16S, Transplantation, Metagenome, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.